OsoBio Appoints Boyer President

Milton Boyer has been named president of OSO Biopharmaceuticals Manufacturing and also joins the company’s board of directors. Mr. Boyer has served as vice president of business development and sales since 2008, guiding business strategies and creating new growth opportunities. He will continue to update and expand OsoBio’s operational capabilities, expand the company’s talent pool, and drive operational efficiencies.

Mr. Boyer has more than 20 years of experience in fine chemical and pharmaceutical business development with special expertise in APIs and narcotic raw materials. He previously served as director of sales and marketing for Siegfried-USA and Chattem Chemicals, Inc. He serves on the board of directors at the Drug, Chemical and Associated Technology Association (DCAT), and is a member of the International Society of Pharmaceutical Engineers (ISPE) and the American Association of Pharmaceutical Scientists (AAPS).

“Our mission at OsoBio remains focused on building an injectable drug contract manufacturing organization that distinguishes itself with world-class customer service,” said George Aitken-Davies, board member. “Milton has demonstrated continued commitment to this vision by developing strategic customer relationships and driving significantly increased visibility of OsoBio in the market. We are confident that Milton’s leadership skills will help us achieve the bold and ambitious goals we’ve set for 2012 and beyond.”